Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04289779
Title Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE) (ABATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Deepak Kilari
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab + Cabozantinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.